Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Duffy

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Plos One|February 4, 2014
Adverse events profile of PrePex a non-surgical device for adult male circumcision in a Ugandan urban settingMoses Galukande, Kevin Duffy, Jean Paul Bitega, et al.
Journal of Immigrant and Minority Health|August 30, 2011
Investigating the myth of the "model minority": a participatory community health assessment of Chinese and Vietnamese adultsShalini Ahuja Tendulkar, Renée Cammarata Hamilton, Chieh Chu, et al.
Synapse (New York, N.Y.)|March 1, 2017
Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [<sup>11</sup> C]PBR28W Gordon Frankle, Rajesh Narendran, Andrew T Wood, et al.
American Heart Journal|February 26, 2008
Clinical utility of automated assessment of left ventricular ejection fraction using artificial intelligence-assisted border detectionHind W Rahmouni, Bonnie Ky, Ted Plappert, et al.
Biochemistry|October 7, 2008
Biochemical characterization of human prolyl hydroxylase domain protein 2 variants associated with erythrocytosisMelissa B Pappalardi, John D Martin, Yong Jiang, et al.
Blood|November 7, 2015
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignanciesHarriet S Walter, Simon A Rule, Martin J S Dyer, et al.
Molecular Cancer Therapeutics|May 8, 2026
Tri-specific Humabody CB307 Targeting CD137, Prostate-specific Membrane Antigen, and Human Serum Albumin Whole-body Biodistribution Measured with 89Zr-CB307 PETDaan G Knapen, Claudia Aj van Winkel, Tom Grevelink, et al.
Blood|February 23, 2023
Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphomaClaire Roddie, Lazaros J Lekakis, Maria A V Marzolini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2025
A phase I dose escalation and cohort expansion study of CB307, a trispecific Humabody® against PSMA, CD137, and albumin in patients with PSMA-positive solid tumorsJohann S de Bono, Anja Williams, Ignacio Melero, et al.
Nature Medicine|October 13, 2021
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trialShaun Cordoba, Shimobi Onuoha, Simon Thomas, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Plos One|February 4, 2014
Adverse events profile of PrePex a non-surgical device for adult male circumcision in a Ugandan urban settingMoses Galukande, Kevin Duffy, Jean Paul Bitega, et al.
Journal of Immigrant and Minority Health|August 30, 2011
Investigating the myth of the "model minority": a participatory community health assessment of Chinese and Vietnamese adultsShalini Ahuja Tendulkar, Renée Cammarata Hamilton, Chieh Chu, et al.
Synapse (New York, N.Y.)|March 1, 2017
Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [<sup>11</sup> C]PBR28W Gordon Frankle, Rajesh Narendran, Andrew T Wood, et al.
American Heart Journal|February 26, 2008
Clinical utility of automated assessment of left ventricular ejection fraction using artificial intelligence-assisted border detectionHind W Rahmouni, Bonnie Ky, Ted Plappert, et al.
Biochemistry|October 7, 2008
Biochemical characterization of human prolyl hydroxylase domain protein 2 variants associated with erythrocytosisMelissa B Pappalardi, John D Martin, Yong Jiang, et al.
Blood|November 7, 2015
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignanciesHarriet S Walter, Simon A Rule, Martin J S Dyer, et al.
Molecular Cancer Therapeutics|May 8, 2026
Tri-specific Humabody CB307 Targeting CD137, Prostate-specific Membrane Antigen, and Human Serum Albumin Whole-body Biodistribution Measured with 89Zr-CB307 PETDaan G Knapen, Claudia Aj van Winkel, Tom Grevelink, et al.
Blood|February 23, 2023
Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphomaClaire Roddie, Lazaros J Lekakis, Maria A V Marzolini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2025
A phase I dose escalation and cohort expansion study of CB307, a trispecific Humabody® against PSMA, CD137, and albumin in patients with PSMA-positive solid tumorsJohann S de Bono, Anja Williams, Ignacio Melero, et al.
Nature Medicine|October 13, 2021
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trialShaun Cordoba, Shimobi Onuoha, Simon Thomas, et al.
Pageof 2